Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Hardly a month after retiring as chief scientific officer of Gilead Sciences, Norbert Bischofberger is leading a new company called Kronos Bio, which has announced raising $18 million in seed financing. The Cambridge, Mass.-based start-up will use small-molecule microarrays refined by Kronos’s scientific founder and MIT chemist Angela Koehler to discover compounds that modulate or degrade traditionally tough-to-target proteins implicated in cancer.
This article has been sent to the following recipient: